SCHEMBL21738239

SCHEMBL21738239

Cc1[nH]cc(C(F)(F)F)c1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14105505 0.77 ALDH1A1 (0.32)
SCHEMBL17897636 0.76 P2RX7 (0.36)
SCHEMBL20643358 0.73
SCHEMBL27261259 0.72 KDM4E (0.46)
SCHEMBL6988660 0.70 KDM4E (0.34)
SCHEMBL6573412 0.70 NOTUM (0.57)
SCHEMBL20844117 0.65
SCHEMBL20393126 0.65 SMN1; SMN2 (0.37)
SCHEMBL15639192 0.64 AR (0.44)
SCHEMBL873423 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020036437-A1 SUBSTITUTED HETEROARYL DERIVATIVE, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING PROTEIN KINASE-RELATED DISEASES WHICH CONTAINS SAME AS ACTIVE INGREDIENT 재단법인 대구경북첨단의료산업진흥재단 2020-02-20 WO disclosed